alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>   1


                                                                            
                                                                     Exhibit 11


                             SUMMIT TECHNOLOGY, INC.

<TABLE>

                     STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS
<CAPTION>


                                                            THREE MONTHS            NINE MONTHS
                                                         ENDED SEPTEMBER 30,      ENDED SEPTEMBER 30,
  (IN THOUSANDS, EXCEPT PER SHARE  AMOUNT                 1996        1995         1996         1995
  -----------------------------------------------------------------------------------------------------

  <S>                                                   <C>          <C>         <C>           <C>     
  Net income (loss)                                     $(3,941)     $   536     $(19,475)     $(3,511)
  Primary income (loss) per share:
  Common Stock                                           30,963       26,959       30,950       26,936
  Stock Options                                               -          389            -            -
                                                        -------      -------     --------      ------- 
  Weighted average common shares outstanding             30,963       27,348       30,950       26,936
                                                        -------      -------     --------      -------
  Income (loss) per share                               $  (.13)     $   .02     $   (.63)     $  (.13)
                                                        -------      -------     --------      -------
  Fully diluted income (loss) per share:
  Common Stock                                           30,963       26,957       30,950       26,936
  Stock Options                                               -          392            -            -
                                                        -------      -------     --------      ------- 
  Weighted average common shares outstanding             30,963       27,349       30,950       26,936
                                                        -------      -------     --------      ------- 
  Income (loss) per share                               $  (.13)     $   .02     $   (.63)     $  (.13)
                                                        -------      -------     --------      ------- 
</TABLE>
Exhibit 32
 Certification Pursuant to 18 U.S.C. Section 1350 as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  1.
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, and2.
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
 AXS-ONE INC.Date:April 30, 2009
    By:
    /s/ William P. LyonsWilliam P. LyonsChairman of the Board and Chief Executive OfficerBy:
    /s/ Joseph P. DwyerJoseph P. DwyerExecutive Vice President, Chief Financial Officer,
and Treasurer
# L_2020088EN.01001001.xml

| 24.3.2020 | EN | Official Journal of the European Union | L 88/10 |
| --- | --- | --- | --- |

24.3.2020

EN

Official Journal of the European Union

L 88/10

---

Corrigendum to Council Decision (EU) 2019/1355 of 15 July 2019 on the position to be taken on behalf of the European Union in the EPA Committee established under the stepping stone Economic Partnership Agreement between Côte d’Ivoire, of the one part, and the European Community and its Member States, of the other part, as regards the adoption of Protocol 1 concerning the definition of the concept of ‘originating products’ and methods of administrative cooperation

(
  Official Journal of the European Union L 222 of 26 August 2019
  )

| 1. | On page 18, the Annex to the draft decision of the EPA committee, Protocol 1, in Article 17(1) and (2): |
| --- | --- |

1.

On page 18, the Annex to the draft decision of the EPA committee, Protocol 1, in Article 17(1) and (2):

for:

‘1.   Products originating in the European Union shall, on importation into Côte d’Ivoire, benefit from the Agreement upon the submission of an origin declaration, in the cases specified in Article 22(1) of this Protocol ...

2.   Products originating in Côte d’Ivoire shall ...:

| (a) | ...; |
| --- | --- |

(a)

...;

| (b) | in the cases specified in Article 22(1) of this Protocol ...’, |
| --- | --- |

(b)

in the cases specified in Article 22(1) of this Protocol ...’,

read:

‘1.   Products originating in the European Union shall, on importation into Côte d'Ivoire, benefit from the Agreement upon the submission of an origin declaration, in the cases specified in Article 21(1) of this Protocol ...

2.   Products originating in Côte d'Ivoire shall ...:

| (a) | ...; |
| --- | --- |

(a)

...;

| (b) | in the cases specified in Article 21(1) of this Protocol ...’. |
| --- | --- |

(b)

in the cases specified in Article 21(1) of this Protocol ...’.

| 2. | On page 24, the Annex to the draft decision of the EPA committee, Protocol 1, in Article 31(1) to (2): |
| --- | --- |

2.

On page 24, the Annex to the draft decision of the EPA committee, Protocol 1, in Article 31(1) to (2):

for:

‘1.   1. For the application of Article 21(1)(b) and Article 26(3) of this Protocol in cases where products are invoiced in a currency other than euro ...

2.   A consignment shall benefit from the provisions of Article 22(1)(b) or Article 27(3) of this Protocol by reference to the currency in which the invoice is drawn up ...’,

read:

‘1.   For the application of Article 21(1)(c) and Article 26(3) of this Protocol in cases where products are invoiced in a currency other than euro ...

2.   A consignment shall benefit from the provisions of Article 21(1)(c) or Article 26(3) of this Protocol by reference to the currency in which the invoice is drawn up ...’.

---
§ 812.46 Monitoring investigations. ( a ) *Securing compliance.* A sponsor who discovers that an investigator is not complying with the signed agreement, the investigational plan, the requirements of this part or other applicable FDA regulations, or any conditions of approval imposed by the reviewing IRB or FDA shall promptly either secure compliance, or discontinue shipments of the device to the investigator and terminate the investigator's participation in the investigation. A sponsor shall also require such an investigator to dispose of or return the device, unless this action would jeopardize the rights, safety, or welfare of a subject.
( b ) *Unanticipated adverse device effects.* ( 1 ) A sponsor shall immediately conduct an evaluation of any unanticipated adverse device effect.
( 2 ) A sponsor who determines that an unanticipated adverse device effect presents an unreasonable risk to subjects shall terminate all investigations or parts of investigations presenting that risk as soon as possible. Termination shall occur not later than 5 working days after the sponsor makes this determination and not later than 15 working days after the sponsor first received notice of the effect.
( c ) *Resumption of terminated studies.* If the device is a significant risk device, a sponsor may not resume a terminated investigation without IRB and FDA approval. If the device is not a significant risk device, a sponsor may not resume a terminated investigation without IRB approval and, if the investigation was terminated under paragraph (b)(2) of this section, FDA approval.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                           55289
<SECURITIES>                                     37660
<RECEIVABLES>                                     4372
<ALLOWANCES>                                         0
<INVENTORY>                                        131
<CURRENT-ASSETS>                                102270
<PP&E>                                            7313
<DEPRECIATION>                                    3113
<TOTAL-ASSETS>                                  127732
<CURRENT-LIABILITIES>                            20538
<BONDS>                                            145
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            99
<OTHER-SE>                                      106950
<TOTAL-LIABILITY-AND-EQUITY>                    127732
<SALES>                                          40147
<TOTAL-REVENUES>                                 40147
<CGS>                                            31132
<TOTAL-COSTS>                                    31132
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  83
<INCOME-PRETAX>                                  12539
<INCOME-TAX>                                      4304
<INCOME-CONTINUING>                               8234
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                          128
<NET-INCOME>                                      8362
<EPS-PRIMARY>                                     0.93
<EPS-DILUTED>                                     0.92
        

</TABLE>
§ 830.360 Records to be maintained by the labeler. ( a ) Each labeler shall retain, and submit to FDA upon specific request, records showing all unique device identifiers (UDIs) used to identify devices that must bear a UDI on their label, and the particular version or model associated with each device identifier. These records must be retained for 3 years from the date the labeler ceases to market the version or model.
( b ) Compliance with this section does not relieve the labeler of the need to comply with recordkeeping requirements of any other FDA regulation.
§ 582.6769 Sodium metaphosphate. ( a ) *Product.* Sodium metaphosphate.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
Searched for **https://www.invasivespeciesinfo.gov/**

 

19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

*Note:* This calendar view maps the number of captures of **https://www.invasivespeciesinfo.gov/**, *not* how many times the site was actually updated.

Look Up URL in general Internet Archive web collection.
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<MULTIPLIER>                                    1,000
<PERIOD-TYPE>                                    YEAR
<FISCAL-YEAR-END>                          DEC-01-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-01-1996
<CASH>                                           2,873
<SECURITIES>                                         0
<RECEIVABLES>                                    6,188
<ALLOWANCES>                                         0
<INVENTORY>                                     41,804
<CURRENT-ASSETS>                                65,498
<PP&E>                                          28,074
<DEPRECIATION>                                 (4,937)
<TOTAL-ASSETS>                                 111,355
<CURRENT-LIABILITIES>                          100,432
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            25
<OTHER-SE>                                       7,005
<TOTAL-LIABILITY-AND-EQUITY>                   111,355
<SALES>                                         92,800
<TOTAL-REVENUES>                                92,800
<CGS>                                           88,478
<TOTAL-COSTS>                                   88,478
<OTHER-EXPENSES>                              (10,260)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             (4,490)
<INCOME-PRETAX>                                (5,938)
<INCOME-TAX>                                     (160)
<INCOME-CONTINUING>                            (6,914)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (4,674)
<EPS-PRIMARY>                                   (0.19)
<EPS-DILUTED>                                   (0.19)

</TABLE>
Fw: Updated MATS RIA for OMB Distribution (Message 2 of 3) RobertJ Wayland to: Cortney_Higgins 11/23/2011 02:41 PM Cc: Bill Maxwell

Cortney -

Attached are the remaining chapters of the revised/updated RIA.

Hope you have a great Thanksgiving and get some time to spend with family and friends!

Happy Thanksgiving!

bob

Robert J. Wayland, Ph.D. Leader, Energy Strategies Group U.S. Environmental Protection Agency Office of Air Quality Planning & Standards Sector Policies and Programs Division Mail Code D243-01 RTP, NC 27711

Phone: (919) 541-1045 Cell: (919) 306-2290 Fax: (919) 541-5450

e-mail: wayland.robertj@epa.gov

********************************************************* DRAFT/Deliberative Document -- FOIA Exempt

*********************************************************

Chapter 6_EmploymentImpactAnalysis_1123.docx

Chapter 7_StatutoryandExecutiveOrderAnalyses_1123.doc

Chapter 8_SummaryofCostsandBenefits_1123.doc
# C_2014142EN.01001001.xml

| 12.5.2014 | EN | Official Journal of the European Union | C 142/10 |
| --- | --- | --- | --- |

12.5.2014

EN

Official Journal of the European Union

C 142/10

---

Reference for a preliminary ruling from the Fövárosi Ítelőtábla lodged on 27 January 2014 — Criminal proceedings against Isztván Balázs and Dániel Papp

(Case C-45/14)

2014/C 142/12

Language of the case: Hungarian

Referring court

Referring court

Fővárosi Ítelőtábla

Party/parties to the main proceedings

Party/parties to the main proceedings

Defendants: Isztván Balázs and Dániel Papp

Defendants

Other party: Fővárosi Fellebbviteli Főügyészség

Other party

Question(s) referred

Question(s) referred

The Court of Justice is asked give a preliminary ruling on the question whether the rules or lack of rules on lawful accusation in Paragraph 2 of the Hungarian Law on criminal procedure

| 1. | Breach the ‘right to an effective remedy and to a fair trial’ enshrined in Article 47 of the Charter of Fundamental Rights of the European Union? |
| --- | --- |

1.

Breach the ‘right to an effective remedy and to a fair trial’ enshrined in Article 47 of the Charter of Fundamental Rights of the European Union?

| 2. | Result in the breach of the ‘right not to be tried or punished twice in criminal proceedings for the same criminal offence’ enshrined in Article 50 of the Charter of Fundamental Rights of the European Union, in Article 14(7) of the International Covenant on Civil and Political Rights and in Article 4(1) of Protocol No 7 of the European Convention for the Protection of Human Rights and Fundamental Freedoms signed in Rome on 4 November 1950? |
| --- | --- |

2.

Result in the breach of the ‘right not to be tried or punished twice in criminal proceedings for the same criminal offence’ enshrined in Article 50 of the Charter of Fundamental Rights of the European Union, in Article 14(7) of the International Covenant on Civil and Political Rights and in Article 4(1) of Protocol No 7 of the European Convention for the Protection of Human Rights and Fundamental Freedoms signed in Rome on 4 November 1950?

| 3. | Result in the breach of the ‘prohibition of abuse of rights’ laid down by Article 54 of the Charter of Fundamental Rights of the European Union? |
| --- | --- |

3.

Result in the breach of the ‘prohibition of abuse of rights’ laid down by Article 54 of the Charter of Fundamental Rights of the European Union?

---
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              MAR-31-2001
<PERIOD-START>                                 APR-01-2000
<PERIOD-END>                                   SEP-30-2000
<CASH>                                                 231
<SECURITIES>                                             0
<RECEIVABLES>                                        1,212
<ALLOWANCES>                                           (12)
<INVENTORY>                                          1,646
<CURRENT-ASSETS>                                     3,333
<PP&E>                                               1,130
<DEPRECIATION>                                        (750)
<TOTAL-ASSETS>                                       4,135
<CURRENT-LIABILITIES>                                2,104
<BONDS>                                                  0
<PREFERRED-MANDATORY>                                    0
<PREFERRED>                                              0
<COMMON>                                               211
<OTHER-SE>                                           1,521
<TOTAL-LIABILITY-AND-EQUITY>                         4,135
<SALES>                                              3,242
<TOTAL-REVENUES>                                     3,242
<CGS>                                                1,683
<TOTAL-COSTS>                                        2,840
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                     (53)
<INCOME-PRETAX>                                        350
<INCOME-TAX>                                           141
<INCOME-CONTINUING>                                    209
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                           209
<EPS-BASIC>                                            .10
<EPS-DILUTED>                                          .10



</TABLE>
[Federal Register Volume 75, Number 43 (Friday, March 5, 2010)]
[Notices]
[Page 10309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4664]


-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

U.S. Geological Survey


Announcement of National Geospatial Advisory Committee Meeting

AGENCY: U.S. Geological Survey, Interior.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The National Geospatial Advisory Committee (NGAC) will meet on 
March 24-25, 2010 at the One Washington Circle Hotel, 1 Washington 
Circle, NW., Washington, DC 20037. The meeting will be held in the 
Meridian Room. The NGAC, which is composed of representatives from 
governmental, private sector, non-profit, and academic organizations, 
was established to advise the Chair of the Federal Geographic Data 
Committee on management of Federal geospatial programs, the development 
of the National Spatial Data Infrastructure, and the implementation of 
Office of Management and Budget (OMB) Circular A-16. Topics to be 
addressed at the meeting include:

--Welcome to New Committee Members
--NGAC Overview/History of Federal Geospatial Coordination
--Leadership Dialogue
--Place-Based Policies
--Subcommittee Reports
--Current FGDC Activities
--Review of FGDC Guidance/NGAC Action Plan
    The meeting will include an opportunity for public comment on March 
25. Comments may also be submitted to the NGAC in writing. Members of 
the public who wish to attend the meeting must register in advance. 
Please register by contacting Arista Maher at the U.S. Geological 
Survey (703-648-6283, <a href="/cdn-cgi/l/email-protection#51303c3039342311242236227f363e27"><span class="__cf_email__" data-cfemail="c0a1ada1a8a5b280b5b3a7b3eea7afb6">[email protected]</span></a>). Registrations are due by March 
19, 2010. While the meeting will be open to the public, seating may be 
limited due to room capacity.

DATES: The meeting will be held from 8:30 a.m. to 5 p.m. on March 24 
and from 8:30 a.m. to 4:30 p.m. on March 25.

FOR FURTHER INFORMATION CONTACT: John Mahoney, U.S. Geological Survey 
(206-220-4621).

SUPPLEMENTARY INFORMATION: Meetings of the National Geospatial Advisory 
Committee are open to the public. Additional information about the NGAC 
and the meeting is available at http://www.fgdc.gov/ngac.

    Dated: March 1, 2010.
Ken Shaffer,
Deputy Executive Director, Federal Geographic Data Committee.
[FR Doc. 2010-4664 Filed 3-4-10; 8:45 am]
BILLING CODE 4311-AM-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# C_2015294EN.01006002.xml

| 7.9.2015 | EN | Official Journal of the European Union | C 294/60 |
| --- | --- | --- | --- |

7.9.2015

EN

Official Journal of the European Union

C 294/60

---

Order of the General Court of 9 June 2015 — Schumacher Packaging v Commission

(Case T-265/14) (1)

1

((State aid - Measures adopted by Germany in favour of electricity generated from renewable energy sources and of energy-intensive undertakings - Decision to open the procedure under Article 108(2) TFEU - Adoption of the final decision after the action was brought - No need to adjudicate))

(2015/C 294/73)

Language of the case: German

Parties

Parties

Applicant: Schumacher Packaging GmbH (Schwarzenberg, Germany) (represented by: H. Janssen and G.-R. Engel, lawyers)

Applicant:

Defendant: European Commission (represented by: T. Maxian Rusche and R. Sauer, acting as Agents, and by A. Luke and C. Maurer, lawyers)

Defendant:

Re:

Re:

Application to annul in part Commission decision C (2013) 4424 final of 18 December 2013 to open the procedure under Article 108(2) TFEU regarding measures implemented by the Federal Republic of Germany in favour of renewable electricity and of energy-intensive users (State aid SA.33995 (2013/C) (ex 2013/NN)).

Operative part of the order

Operative part of the order

| 1. | There is no longer any need to adjudicate on the present action. |
| --- | --- |

1.

There is no longer any need to adjudicate on the present action.

| 2. | There is no longer any need to adjudicate on the application for intervention submitted by the EFTA Surveillance Authority. |
| --- | --- |

2.

There is no longer any need to adjudicate on the application for intervention submitted by the EFTA Surveillance Authority.

| 3. | Schumacher Packaging GmbH shall bear its own costs and those incurred by the European Commission. |
| --- | --- |

3.

Schumacher Packaging GmbH shall bear its own costs and those incurred by the European Commission.

| 4. | The EFTA Surveillance Authority shall bear its own costs. |
| --- | --- |

4.

The EFTA Surveillance Authority shall bear its own costs.

---

(1)  OJ C 223, 14.7.2014.

1

---
Order entered October 2 , 2015

In The



## Court of Appeals

Fifth District of Texas at Dallas

No. 05

- 15

- 00862

- CR

DAVID SHAWN FOTHERGI LL, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 15th Judicial District Court

Grayson County, Texas

Tria l Court Cause No. 063259



### O RDER

The Court REINSTATE S the appeal.

On September 30, 2015, we ordered the trial court to make findings regarding why

appellant’s brief had not been filed. On October 1, 2015, we received appellant’s brief, together

with an ex tension motion. Therefore, findings are no longer necessary and we VACATE our

September 30, 2015 order.

We GRANT the October 1, 2015 extension motion and ORDER appellant’s brief filed

as of the date of this order.

/s/ ADA BROWN

JUSTICE